The National Institutes of Health, through its NIH Guide, has recently published the following funding-related policy notices, general notices, notices of changes, notices of special interest NOSI, and funding opportunities:

General Notices

• Notice to Extend the Response Date for NOT-AT-20-013 "Request for Information: Soliciting Input for the National Center for Complementary and Integrative Healths New Strategic Plan"
  National Center for Complementary and Integrative Health

• Notice of Interest in Advancing Research on FMR1-Associated Conditions
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Center for Advancing Translational Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke

• Notice of NICHD Participation in NOT-EB-20-012 "Notice of Change in Application Due Date for PAR-19-215 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)"
  Eunice Kennedy Shriver National Institute of Child Health and Human Development

• Notice Announcing the Availability of Common Data Elements for Research Related to the Public Health Emergency caused by Coronavirus Disease 2019 (COVID-19)
  National Institute of Mental Health

• Findings of Research Misconduct
  National Institutes of Health

• Notice of Participation of the Environmental Influences on Child Health Outcomes (ECHO) in PA-18-591 "Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)"
  National Institutes of Health

• Notice of Participation of the Environmental Influences on Child Health Outcomes (ECHO) in PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)"
  National Institutes of Health

Notice of Changes to Funding Opportunities

• Notice of NIA Participation in PA-20-135, "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"
  National Institute on Aging

• Notice of NIDA Participation in PA-20-135, "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"
  National Institute on Drug Abuse

• Notice of NIDCD's Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"
  National Institute on Deafness and Other Communication Disorders

• Rescinding NOT-HG-20-041 NHGRI Late Application Policy for NHGRI-Specific FOAs with Application Due Dates in May, June, and July and Clarifying the Late Application Receipt Dates of NHGRI-Specific FOAs (NOT-HG-20-042)
  National Human Genome Research Institute

• Notice of Change in Application Due Date for RFA-HL-20-029 "Limited Competition: Small Grant Program for NHLBI K01/K08/K23 Recipients (R03 - Clinical Trial Optional)"
  National Heart, Lung, and Blood Institute

• Notice to Extend RFA-MH-20-505, Practice-Based Research for Implementing Scalable Evidence-Based Prevention Interventions in Primary Care Settings (R01 Clinical Trial Optional)
  National Institute of Mental Health

• Notice to Extend RFA-MH-20-506, "Practice-Based Research for Implementing Scalable Evidence-Based Prevention Interventions in Primary Care Settings (R34 Clinical Trial Required)"
  National Institute of Mental Health

• Notice of ORWH Participation in PA-20-135, Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement Clinical Trial Optional)
  Office of Research on Women's Health

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for INIA Administrative Resource (U24 Clinical Trial Not Allowed)
  National Institute on Alcohol Abuse and Alcoholism

• Notice of Intent to Publish a Funding Opportunity Announcement for INIA Research Resource (U24 Clinical Trial Not Allowed)
  National Institute on Alcohol Abuse and Alcoholism

• Notice of Intent to Publish a Funding Opportunity Announcement for Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)
  National Institute on Minority Health and Health Disparities
  National Center for Complementary and Integrative Health
  National Institute on Aging
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health

• Notice of Intent to Publish a Funding Opportunity Announcement for Digital healthcare interventions to address the secondary health effects related to social, behavioral, and economic impact of COVID-19 (R01 - Clinical Trial Optional)
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention

Notices of Special Interest

• Notice of Special Interest (NOSI): Research on Co-morbid Substance Use, Substance Use Disorders, and Other Psychiatric Disorders
  National Institute on Drug Abuse
  Office of Research on Women's Health

• Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders
  National Institute on Deafness and Other Communication Disorders

• Notice of Special Interest (NOSI) of NIDCR in Supporting Dental, Oral, and Craniofacial Research Using Bioinformatic, Computational, and Data Science Approaches
  National Institute of Dental and Craniofacial Research

• Notice of Special Interest: NIGMS Priorities for Small Business Development of Sepsis Diagnostics and Therapeutics
  National Institute of General Medical Sciences

• Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations
  National Institute on Minority Health and Health Disparities
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health

• Notice of Special Interest (NOSI): Chimerism in Marmosets and other New World Primates
  National Institute of Mental Health
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  National Institute of Neurological Disorders and Stroke

• Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19
  National Institute of Mental Health
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health

Funding Opportunities

• Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 No Independent Clinical Trials)
• Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 Basic Experimental Studies with Humans Required)
  NIH Basic Behavioral and Social Science Opportunity Network
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  Office of Behavioral and Social Sciences Research
   
• National Institute of General Medical Sciences Institutional Predoctoral Research Training Grant (T32 - Clinical Trial Not Allowed)
  National Institute of General Medical Sciences
   
• NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional)
  National Institute on Drug Abuse
   
• Avenir Award Program for Research on Substance Use Disorders and HIV/AIDS (DP2 Clinical Trial Optional)
• Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)
  National Institute on Drug Abuse
   
• Alcohol-HIV/AIDS Program Project Comorbidities, Coinfections, and Complications Research: Intervention and Cross-Cutting Foundational Research (P01 Clinical Trial Optional)
  National Institute on Alcohol Abuse and Alcoholism
   
• Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional)
• Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional)
  National Cancer Institute
  National Institute of Allergy and Infectious Diseases
   
• Advancing HIV/AIDS Research through Computational Neuroscience FOA (R01 - Clinical Trial Optional)
  National Institute on Drug Abuse
   
• George M. O'Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)
  National Institute of Diabetes and Digestive and Kidney Diseases
   
• Advancing Genomic Medicine Research (Clinical Trial Optional) (R01)
• Advancing Genomic Medicine Research (Clinical Trial Optional) (R21)
  National Human Genome Research Institute
   
• Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
  National Heart, Lung, and Blood Institute
  National Center for Advancing Translational Sciences
  National Eye Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Neurological Disorders and Stroke
   

Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu  or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu  or Dave Myers at dave-myers@uiowa.edu  or Lynn Hudachek at lynn-hudachek @uiowa.edu